93 related articles for article (PubMed ID: 19737480)
1. [Inhibitory and lethal effects of human-mouse chimeric antibody against CD80 on the growth of B lymphoma cell lines Raji and Daudi].
Wang YR; Ma HB; Chen YJ; Zhu HT; Liu YH; Du YY; Sun J; Chen MX; Qiu YH
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2009 Jul; 25(7):615-8. PubMed ID: 19737480
[TBL] [Abstract][Full Text] [Related]
2. [Hyperactivation of c-Jun NH(2)-terminal protein kinase contributes to the proliferation of B lymphoma cells].
Guo YY; Cui J; Hou CM; Wang QY; Wang J; Ma YF; Zhang JY
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Feb; 19(1):100-4. PubMed ID: 21362231
[TBL] [Abstract][Full Text] [Related]
3. [Apoptosis of human B cell lymphoma Raji cells induced by monovalent anti-CD20 antibody].
Liu YX; Fan DM; Xiong DS; Xu YF; Shao XF; Xu YS; Peng H; Yang M; Qin L; Zhu ZP; Yang CZ
Ai Zheng; 2003 Dec; 22(12):1249-53. PubMed ID: 14693045
[TBL] [Abstract][Full Text] [Related]
4. [Effect of CD(40) on the in vitro biological behavior of malignant B lymphocytes].
Shi H; Qi C; Zhuang Y; Gu Z; Yu G; Zhao W; Zhang X
Zhonghua Xue Ye Xue Za Zhi; 2002 Aug; 23(8):420-4. PubMed ID: 12411046
[TBL] [Abstract][Full Text] [Related]
5. [Therapeutic effect of agonistic CD40 monoclonal antibody combined with CTL on hu-SCID mouse B lymphoma model].
Zhou H; Xi H; Ma QR; Chen C; Zhang F; Zhang XG; Gu ZJ
Zhonghua Zhong Liu Za Zhi; 2007 Mar; 29(3):181-5. PubMed ID: 17649632
[TBL] [Abstract][Full Text] [Related]
6. Mda‑7/IL‑24 induces the differentiation of B cell lymphoma via activation of the P38 mitogen activated protein kinase signaling pathway.
Ma M; Yang X; Zhao L; Liu L; Zhang C; Wang X; Shan B
Mol Med Rep; 2017 Oct; 16(4):5633-5642. PubMed ID: 28849038
[TBL] [Abstract][Full Text] [Related]
7. Mda-7/IL-24 enhances sensitivity of B cell lymphoma to chemotherapy drugs.
Ma M; Zhao L; Sun G; Zhang C; Liu L; Du Y; Yang X; Shan B
Oncol Rep; 2016 May; 35(5):3122-30. PubMed ID: 26883473
[TBL] [Abstract][Full Text] [Related]
8. [Expression of human-mouse chimeric antibody against CD40 in CHO cell line and characterization of its function].
Qu QX; Chen C; Wang Q; Ge Y; Chen YJ; Qiu YH; Zhang XG
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2007 Jun; 23(6):565-8. PubMed ID: 17553357
[TBL] [Abstract][Full Text] [Related]
9. [Preclinical study of apoptosis of B-NHL cell lines induced by anti-CD20 monoclonal antibody].
Zhang HY; Chen HT; Guan ZZ; Huang Y; Zhang X; Lin TY
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Aug; 17(4):883-7. PubMed ID: 19698222
[TBL] [Abstract][Full Text] [Related]
10. Mechanism of cytotoxicity induced by chimeric mouse human monoclonal antibody IDEC-C2B8 in CD20-expressing lymphoma cell lines.
Flieger D; Renoth S; Beier I; Sauerbruch T; Schmidt-Wolf I
Cell Immunol; 2000 Aug; 204(1):55-63. PubMed ID: 11006018
[TBL] [Abstract][Full Text] [Related]
11. [Effect of CD80-scFv on recognition of CD80 molecule and proliferation of different tumor cells in vitro].
Shen LJ; Han LH; Zhu HT; Kong Y; An M; Wang J; Xia YJ; Qiu YH
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2012 Oct; 28(10):1081-3. PubMed ID: 23046940
[TBL] [Abstract][Full Text] [Related]
12. A novel monoclonal antibody against human CD80 and its immune protection in a mouse lupus-like disease.
Shi Q; Gao ZY; Xie F; Wang LF; Gu YP; Yang TJ; Huang L; Qian QH; Qiu YH
Int J Immunopathol Pharmacol; 2011; 24(3):583-93. PubMed ID: 21978690
[TBL] [Abstract][Full Text] [Related]
13. [Expression of CD16zeta in NK cells of B-cell non-Hodgkin's lymphoma patients and in vitro killing effect of rituximab combined lymphokine-activated killer cells on B-NHL cells].
Shi YX; Zhang XS; Xia JC; Li YQ; Xu RH; Han WJ; Zhang JH; Guan ZZ; Jiang WQ
Ai Zheng; 2007 Aug; 26(8):837-42. PubMed ID: 17697543
[TBL] [Abstract][Full Text] [Related]
14. [Blocking the escape of leukemic cells from killing of T cell by combining anti-Fas ribozyme and CD80-IgG fusion protein].
Liu LB; Li WM; He W; Zhang M; Xiao J; Zhong ZD; Li L; Zou P
Zhonghua Yi Xue Za Zhi; 2005 Dec; 85(49):3469-74. PubMed ID: 16686062
[TBL] [Abstract][Full Text] [Related]
15. [Preparation of mouse monoclonal antibody against human B7-1 (CD80) and its inhibitory effect on tumor cells in vitro].
Yan T; Wang Y; Kong Y; Wang J; Shen L; Qiu Y
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2018 Apr; 34(4):302-308. PubMed ID: 29973319
[TBL] [Abstract][Full Text] [Related]
16. Pro-apoptotic effect of an anti-CD37 scFv-Fc fusion protein, in combination with the anti-CD20 antibody, ofatumumab, on tumour cells from B-cell malignancies.
Smolewski P; Robak P; Cebula-Obrzut B; Misiewicz M; Mędra A; Majchrzak A; Witkowska M; Stromatt S; Robak T
Eur J Cancer; 2014 Oct; 50(15):2677-84. PubMed ID: 25154027
[TBL] [Abstract][Full Text] [Related]
17. Rituximab (chimeric anti-CD20) sensitizes B-NHL cell lines to Fas-induced apoptosis.
Vega MI; Huerta-Yepez S; Jazirehi AR; Garban H; Bonavida B
Oncogene; 2005 Dec; 24(55):8114-27. PubMed ID: 16103877
[TBL] [Abstract][Full Text] [Related]
18. [Human/mouse chimeric anti-CD20 monoclonal antibody enhances antigen presentation in dendritic cells and induces anti-lymphoma CTL effects].
Ai LM; Ren HY; Shi YJ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Dec; 15(6):1247-52. PubMed ID: 18088477
[TBL] [Abstract][Full Text] [Related]
19. Tumor growth suppression by a mouse/human chimeric anti-CEA antibody and lymphokine-activated killer cells in vitro and in SCID mouse xenograft model.
Senba T; Kuroki M; Arakawa F; Yamamoto T; Kuwahara M; Haruno M; Ikeda S; Matsuoka Y
Anticancer Res; 1998; 18(1A):17-24. PubMed ID: 9568050
[TBL] [Abstract][Full Text] [Related]
20. [Experimental study of extract from Prunella vulgaris inducing B, T lymphoma cell apoptosis].
Fu XR; Sun ZC; Zhang MZ
Zhong Yao Cai; 2012 Mar; 35(3):433-8. PubMed ID: 22876685
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
